Increased expression of renal neutral endopeptidase in severe heart failure
- 1 October 2002
- journal article
- Published by Elsevier in Life Sciences
- Vol. 71 (23) , 2701-2712
- https://doi.org/10.1016/s0024-3205(02)01990-2
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The control of microvascular permeability and blood pressure by neutral endopeptidaseNature Medicine, 1997
- Role of neutral endopeptidase in the metabolism of endothelin.Hypertension, 1992
- Characterisation of Neutral Endopeptidase 3.4.24.11 (NEP) in the Kidney: Comparison Between Normotensive, Genetically Hypertensive and Experimentally Hypertensive RatsJournal of Enzyme Inhibition, 1991
- Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure.Circulation, 1990
- Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidneyPeptides, 1988
- Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivoKidney International, 1987
- Atrial Natriuretic Factor in Acute and Chronic Cardiac FailureJournal of Cardiovascular Pharmacology, 1987
- Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.Journal of Clinical Investigation, 1986
- Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart FailureNew England Journal of Medicine, 1986
- Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the HumanScience, 1986